A. Moser

发表

Adrenoleukodystrophy

H. Moser, A. Moser, B. O'neill, 1998, Neurology.

Neonatal adrenoleukodystrophy Impaired plasmalogen biosynthesis and peroxisomal β-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts

H. Moser, R. Schutgens, R. Wanders, 1987, Journal of the Neurological Sciences.

Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy

A. Moser, G. Raymond, E. Mowry, 2021, medRxiv.

Determination of 30 X‐linked adrenoleukodystrophy mutations, including 15 not previously described

H. Moser, H. Seuánez, A. Moser, 2000, Human mutation.

Adrenoleukodystrophy: Phenotypic variability and implications for therapy

H. Moser, A. Moser, J. Ott, 1992, Journal of Inherited Metabolic Disease.

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy

H. Moser, A. Moser, L. Nagae-Poetscher, 2003, Neurology.

Docosahexaenoic acid therapy in peroxisomal diseases

G. Raymond, J. Sunness, N. Brereton, 2010, Neurology.

Cytosolic compartmentalization of hepatic alanine: Glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolism

H. Moser, A. Moser, D. Devivo, 1994, Journal of Inherited Metabolic Disease.

Peroxisomal bifunctional enzyme deficiency.

A. Moser, P. Watkins, R. Kelley, 1989, The Journal of clinical investigation.